IP Library Assignment 071337/0132
Patent Assignment
Reel/Frame 071337/0132

Security Interest

Recorded: 2025-05-22 Pages: 13
Assignor
OPTINOSE, INC.
Executed: 2025-05-21
Assignee
OAKTREE FUND ADMINISTRATION, LLC
333 S. GRAND AVENUE, 28TH FL., LOS ANGELES, CALIFORNIA, 90071
Covered Properties (65)
Nasal Administration
Application: 18/079,334 →
Publication: US US20230166061A1
Nasal Delivery Devices
Application: 18/582,740 →
Publication: US US20240316297A1
Nasal Delivery Devices
Application: 18/753,474 →
Publication: US US20250082876A1
Delivery Device and Method
Application: 18/800,200 →
Publication: US US20250082875A1
Methods for Treating Chronic Rhinosinusitis
Application: 18/179,178 →
Publication: US US20230285278A1
Nasal Delivery Devices
Application: 17/305,269 →
Publication: US US20220152324A1
Nasal Delivery Devices
Application: 16/525,716 →
Publication: US US20200023146A1
Nasal Administration
Application: 18/643,434 →
Publication: US 2025/0090778
Exhalation Delivery System for and Method of Treating Sinus Disease
Application: 17/281,290 →
Publication: US US20220296825A1
Intranasal Administration
Application: 18/889,476 →
Publication: US US20250114543A1
Nasal Delivery Devices
Application: 19/027,278 →
Publication: US US20250235642A1
Nasal Delivery
Application: 19/027,027 →
Publication: US US20250262395A1
Nasal Administration
Application: 14/315,132 →
Publication: US US20150144129A1
Delivery Device and Method
Application: 12/279,285 →
Publication: US US20100057047A1
Nasal Delivery Devices
Application: 17/305,260 →
Publication: US US20220031980A1
Powder Delivery Devices
Application: 15/879,009 →
Publication: US US20180272085A1
Intranasal Administration
Application: 17/162,475 →
Publication: US US20210275761A1
Intranasal Administration
Application: 17/338,962 →
Publication: US US20210322690A1
Delivery of Gases to the Nasal Airway
Application: 16/986,692 →
Publication: US US20210085907A1
Nosepiece Unit
Patent: 761,951 →
Application: 29/455,733 →
Nosepiece Unit
Patent: 759,805 →
Application: 29/517,305 →
Nosepiece Unit
Patent: 773,644 →
Application: 29/517,303 →
Nosepiece Unit
Patent: 809,128 →
Application: 29/567,592 →
Nasal Delivery Device
Patent: 723,156 →
Application: 29/455,727 →
Nasal Delivery Device
Patent: 725,769 →
Application: 29/455,723 →
Delivery Devices
Patent: 9,038,630 →
Application: 12/516,399 →
Publication: US US20110126830A1
Nasal Delivery Devices
Patent: 9,010,325 →
Application: 12/516,404 →
Publication: US US20100300439A1
Nasal Delivery Devices
Application: 14/380,801 →
Publication: US US20150013677A1
Nasal Delivery Devices
Application: 14/380,827 →
Publication: US US20150013670A1
Nasal Delivery Devices
Application: 14/380,836 →
Publication: US US20150246194A1
Nasal Administration
Patent: 9,649,456 →
Application: 12/594,365 →
Publication: US US20100288275A1
Nasal Delivery
Patent: 8,978,647 →
Application: 12/594,361 →
Publication: US US20100282246A1
Nasal Delivery Devices
Patent: 9,067,034 →
Application: 12/681,150 →
Publication: US US20110088690A1
Nasal Delivery Devices
Application: 14/674,103 →
Publication: US US20160051778A1
Nasal Administration
Patent: 8,875,704 →
Application: 14/274,271 →
Publication: US US20140246022A1
Nasal Administration
Application: 15/481,975 →
Publication: US US20170274164A1
Nasal Delivery
Application: 14/618,273 →
Publication: US US20160001022A1
Nasal Delivery Devices
Application: 14/721,097 →
Publication: US US20160101249A1
Nasal Delivery of Oxytocin
Application: 13/823,071 →
Publication: US US20140018295A1
Nasal Delivery
Patent: 9,949,923 →
Application: 14/005,363 →
Publication: US US20140073562A1
Nasal delivery devices
Application: 16/093,174 →
Publication: US US20190290863A1
Delivery Devices
Application: 14/694,300 →
Publication: US US20160074603A1
Delivery Devices
Application: 15/936,251 →
Publication: US US20190099565A1
Nasal Delivery Devices
Application: 16/285,694 →
Publication: US US20190290864A1
Nasal Delivery Devices
Patent: 9,108,015 →
Application: 14/058,647 →
Publication: US US20140041660A1
Nasal Delivery Devices
Application: 14/798,221 →
Publication: US US20160095989A1
Powder Delivery Devices
Patent: 8,899,229 →
Application: 11/816,984 →
Publication: US US20090293873A1
Delivery Devices
Patent: 7,784,460 →
Application: 10/568,391 →
Publication: US US20070186927A1
Nasal Administration
Application: 12/161,466 →
Publication: US US20110114087A1
Nasal Devices
Patent: 7,854,227 →
Application: 10/512,514 →
Publication: US US20060096589A1
Powder Delivery Devices
Patent: 9,144,652 →
Application: 14/491,720 →
Publication: US US20150101605A1
Delivery Devices
Application: 14/864,365 →
Publication: US US20160263334A1
Nasal Delivery
Patent: 8,550,073 →
Application: 12/281,894 →
Publication: US US20090314293A1
Nasal Delivery
Application: 15/051,622 →
Publication: US US20160367772A1
Intranasal Administration
Application: 14/635,561 →
Publication: US US20150165139A1
Nasal Delivery Devices
Patent: 8,590,530 →
Application: 13/471,146 →
Publication: US US20130098362A1
Delivery devices
Patent: 8,800,555 →
Application: 10/570,034 →
Publication: US US20070125371A1
Nasal Delivery
Application: 15/924,536 →
Publication: US US20180311450A1
Delivery of Gases to the Nasal Airway
Patent: 8,910,629 →
Application: 12/375,115 →
Publication: US US20100242959A1
Intranasal Administration
Application: 14/946,442 →
Publication: US US20160331916A1
Nasal Devices
Patent: 7,975,690 →
Application: 10/480,582 →
Publication: US US20050072430A1
Delivery of Gases to the Nasal Airway
Application: 15/869,284 →
Publication: US US20190015621A1
Intranasal Administration
Application: 14/946,389 →
Publication: US US20160310683A1
Nasal devices
Patent: 8,596,278 →
Application: 10/469,106 →
Publication: US US20040112379A1
Delivery Device and Method
Patent: 8,171,929 →
Application: 12/279,291 →
Publication: US US20100051022A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 6, 2009
From: DJUPESLAND, PER GISLE; SHELDRAKE, COLIN DAVID; HAFNER, RODERICK PETER
To: OPTINOSE AS
Reel/Frame 022648/0499 →
Assignment of Assignor's Interest Aug 9, 2013
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 030975/0195 →
Assignment of Assignor's Interest Jan 29, 2016
From: DJUPESLAND, PER GISLE; MAHMOUD, RAMY A.; MESSINA, JOHN
To: OPTINOSE AS
Reel/Frame 037616/0854 →
Assignment of Assignor's Interest Jun 14, 2017
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 042703/0957 →
Assignment of Assignor's Interest Jun 14, 2017
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 042710/0020 →
Assignment of Assignor's Interest Jun 14, 2017
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 042704/0226 →
Security Interest Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
Security Interest Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
Release of Security Agreement Recorded at Reel 044976 Frame 0505 Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
Assignment of Assignor's Interest Aug 31, 2022
From: OPTINOSE AS
To: OPTINOSE, INC.
Reel/Frame 061362/0647 →
Assignment of Assignor's Interest Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
Assignment of Assignor's Interest Dec 12, 2022
From: DJUPESLAND, PER GISLE; MAHMOUD, RAMY A; MESSINA, JOHN
To: OPTINOSE AS
Reel/Frame 062058/0435 →
Assignment of Assignor's Interest Mar 14, 2023
From: OPTINOSE AS
To: OPTINOSE, INC.
Reel/Frame 062974/0206 →
Assignment of Assignor's Interest Aug 25, 2023
From: MAHMOUD, RAMY; MESSINA, JOHN
To: OPTINOSE, INC.
Reel/Frame 064704/0275 →
Change of Address Jan 2, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069811/0401 →
Change of Address Jan 2, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069810/0670 →
Change of Address Jan 2, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069810/0584 →
Change of Address Jan 2, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069811/0555 →
Change of Address Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0322 →
Change of Address Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0320 →
Change of Address Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0279 →
Change of Address Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0523 →
Change of Address Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0458 →
Change of Address Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0362 →
Change of Address Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0360 →